Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis
about
Biomarkers of therapeutic response in multiple sclerosis: current statusImmunomodulatory activity of interferon-betaAn RNA profile identifies two subsets of multiple sclerosis patients differing in disease activityAberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body EcologyReassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosisHow type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian PopulationInterferon-β suppresses murine Th1 cell function in the absence of antigen-presenting cells.Janus-like effects of type I interferon in autoimmune diseases.Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patientsReliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic.Assessing treatment response to interferon-β: is there a role for MRI?miRNA in multiple sclerosis: search for novel biomarkers.Prognostic biomarkers of IFNb therapy in multiple sclerosis patients.Gene expression profiling in MS: a fulfilled promise?Inflammatory cytokines at the summits of pathological signal cascades in brain diseases.Predictors of long-term outcome in multiple sclerosis patients treated with interferon β.
P2860
Q27012726-D18F14C1-61D6-4C76-B153-107EAF58F9D0Q27686768-EBB0D47B-437B-4FBF-B862-7F08AE76FD54Q28275948-C9DCF166-28B3-49AB-91B0-9AF66B929E88Q28299160-FB8D88CD-597C-4FC6-B5CD-2145586E8556Q28740839-6F9C5064-236A-476D-89E0-D363F62DFC93Q33988240-D9176183-3D14-4E5E-B125-BF213F70165FQ34979385-5BFEFBEB-AD10-4CD9-A936-ADACD8E7142FQ35461764-FF178C8C-FC82-45D1-9F14-0BB11F2E865DQ36059960-9592BC8D-0AF2-4501-A9BD-AFA549979C7EQ36562599-23544DF8-3228-4123-8C1E-64499BF39252Q37220186-1FB79009-4C4D-4BBC-9B61-A07F51232693Q37518057-32658634-85F2-4ECF-A70A-8F776AE6A2D1Q38447020-CBDBF211-28EC-41C6-BC7E-DE3E6E30C195Q39098884-DBE622EA-8C93-456D-A32E-C79333E4A111Q44275968-8D8D54B8-15FA-43E1-8242-B34F8D9C955FQ44433702-76487665-AAA2-480E-8AD3-394EFAA09818Q45195733-9C98EB01-AC8D-4BA6-8D4F-362BCB787545
P2860
Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Excessive biologic response to ...... tients with multiple sclerosis
@ast
Excessive biologic response to ...... tients with multiple sclerosis
@en
Excessive biologic response to ...... tients with multiple sclerosis
@nl
type
label
Excessive biologic response to ...... tients with multiple sclerosis
@ast
Excessive biologic response to ...... tients with multiple sclerosis
@en
Excessive biologic response to ...... tients with multiple sclerosis
@nl
prefLabel
Excessive biologic response to ...... tients with multiple sclerosis
@ast
Excessive biologic response to ...... tients with multiple sclerosis
@en
Excessive biologic response to ...... tients with multiple sclerosis
@nl
P2093
P2860
P1433
P1476
Excessive biologic response to ...... tients with multiple sclerosis
@en
P2093
Anupama Josyula
Elizabeth Fisher
Jar-Chi Lee
Jennifer Shrock
M R Sandhya Rani
Richard A Rudick
Richard M Ransohoff
P2860
P304
P356
10.1371/JOURNAL.PONE.0019262
P407
P50
P577
2011-01-01T00:00:00Z